Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025

Rhea-AI Summary

Conavi Medical (OTCQB: CNVIF) will present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025 at 9:30 AM EST at the Arcadian Loft in Downtown Toronto.

Tom Looby, Chief Executive Officer, will host the presentation and take questions. A live webcast will be available and all company webcasts will be archived on the event platform under the Agenda tab. Investors may register to attend and request 1x1 in-person meetings at the conference venue.

TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it will be presenting at the Planet MicroCap Showcase: TORONTO 2025 in partnership with MicroCapClub on Wednesday, October 22, 2025 at 9:30 AM (EST) at the Arcadian Loft in Downtown Toronto. Tom Looby, Chief Executive Officer of Conavi Medical, will be hosting the presentation and answering questions at the conclusion.

To access the live presentation, please use the following information:

Planet MicroCap Showcase: TORONTO 2025 in partnership with MicroCapClub
Date: Wednesday, October 22, 2025
Time: 9:30 AM (Toronto, ON Local Time EST)
Webcast: https://event.summitcast.com/view/34SFNFBix4cZpKNiohrXeh/DLTwF5r9PHHdJkLk2edJp9

If you would like to book 1x1 investor meetings with Conavi Medical, and to attend the Planet MicroCap Showcase: TORONTO 2025 in partnership with MicroCapClub, please make sure you are registered here: REGISTER

1x1 meetings will be scheduled and conducted in person at the conference venue: Arcadian Loft in Downtown Toronto, ON.

The Planet MicroCap Showcase: TORONTO 2025 in partnership with MicroCapClub website is available here: HOME PAGE

If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: AGENDA

About Conavi Medical

Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first to combine intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single device, enabling simultaneous and co-registered imaging of coronary arteries. The first-generation Novasight Hybrid™ System has regulatory clearance in the U.S., Canada, China, and Japan. For more information, visit conavi.com.

About Planet MicroCap

Planet MicroCap is a global multimedia financial news, publishing and events company for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.

If you would like to attend the Planet MicroCap Showcase: TORONTO 2025 in partnership with MicroCapClub, please register here: REGISTER

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of Conavi’s future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to Conavi’s plans for the commercialization of its Novasight Hybrid™ System and expected FDA clearance and the commercial launch of next generation Novasight in the U.S.

These forward-looking statements reflect management’s current beliefs with respect to future events, and are based on information currently available to management that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking statements. Forward-looking statements involve significant risks, uncertainties and assumptions and many factors could cause Conavi’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Such factors and assumptions include, but are not limited to, Conavi’s ability to retain key personnel; its ability to execute on its business plans and strategies; and other factors listed in the “Risk Factors” sections of the joint information circular of Conavi dated August 30, 2024 and in the final short form prospectus of Conavi dated April 15, 2025 (each of which may be viewed at www.sedarplus.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements.

Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions and Conavi has attempted to identify important factors that could cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in forward-looking statements, Conavi cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Conavi expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, investors should not place undue reliance on forward-looking statements. All the forward-looking statements are expressly qualified by the foregoing cautionary statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Contact:
Stefano Picone
Chief Financial Officer
(416) 483-0100

FAQ

When will Conavi Medical (CNVIF) present at the Planet MicroCap Showcase TORONTO 2025?

Conavi Medical will present on Wednesday, October 22, 2025 at 9:30 AM EST.

How can I watch Conavi Medical (CNVIF) presentation on October 22, 2025?

Watch the live webcast via the event platform link; the presentation will also be archived under the Agenda tab.

Who will present for Conavi Medical (CNVIF) at the October 22, 2025 conference?

Tom Looby, Chief Executive Officer, will host the presentation and answer questions.

Can investors book 1x1 meetings with Conavi Medical (CNVIF) at the Planet MicroCap Showcase?

Yes. Registered investors can request 1x1 in-person meetings at the Arcadian Loft; meetings will be scheduled at the conference venue.

Where is the Planet MicroCap Showcase: TORONTO 2025 taking place for Conavi Medical (CNVIF)?

The event location is the Arcadian Loft, Downtown Toronto and the presentation is scheduled for 9:30 AM local time (EST).